There was good correlation between radiology and endoscopy in diagnosing duodenal deformity, but precise diagnosis of active ulceration requires direct vision at endoscopy.6
Should barium-meal examinations be abandoned as initial investigations in dyspepsia and replaced by endoscopy? The lack of trained staff and equipment for endoscopy in most areas at the district general hospital level makes this an unrealistic suggestion. This study emphasizes the importance of the availability of an endoscopy service for the investigation of the upper digestive tract as already recommended by the British Society for Digestive Endoscopy. 7 Generalpractitioner clinical assistants can contribute greatly to providing an adequate endoscopy service, but even with more staff the endoscopy department would not be able to carry out the many investigations for dyspepsia currently performed in the x-ray department. Moreover, initial screening by a combined barium-meal examination and cholecystogram with subsequent endoscopy in selected patients will provide the most accurate diagnostic approach to the problem of dyspepsia.
Conclusions
Dyspepsia is a common complaint, the numbers seen in this study being confirmed by previous larger surveys. Many A reliable estimate of the number of remaining viable tumour cells would be of immense importance in man, but there are few human tumours in which this can be made. Gestational choriocarcinoma and myeloma are two examples. Assay of chronic gonadotrophic hormone excretion in patients with choriocarcinoma has proved of great value in controlling chemotherapy in this disease. An effective drug regimen becomnes quickly apparent, and continuing it can reduce the viable cell population to a level enabling the patient to be cured. In spite of this the tumour masses as observed-for example on chest x-ray film-may take a year or more to resolve finally afiter adequate chemotherapy. In myeloma serial estimations of myeloma protein production can also give a useful indication of response and allow -the continued development of useul chemotherapy.
One of the most important advances which could be made concerming solid tumours in man would be the development of marker systems for assessing accurately the amount of viable tumour. Potentially useful chemotherapy will be overloked if tumour mass is the only criterion of response.
Drug Resistance
Resistance to a chemotherapeutic agent may be cosidered under two main headings: primary and acquired resistance, which together constitute the major problem in cancer chemotherapy. The experimental approach in man has largely been directed against the problem of acquired resistance, and the systems involved have been found ito be highly complex.
Several mechanisms may be operative, such as selective killing of a sensitive population leaving resistant cells, or an adaptive change by the cancer cell. Bresnick2 has listed some of the possible adaptive changes: inhibition of membrane transport; a change in the confirmation of an enzyme rendering it insensitive to the drug; deletion of any enzyme necessary to activate the drug; detoxification of the drug to an inactive compound (by cancer cell or normal issues); an increase in concentration of a metabolite which can overcome the biochemical lesion produced by the drug; an increase in concentration of the target enzyme; a reduced requirement for a metabolite which is a product of the inhibited reaction; and an alternative metabolic pathway which is not inhibited by the drug may develop in the resistant cells.
Changes in tumour cell proliferation is another suggested mechanism for the emergence of drug resistance, and is probably an important mechanism in some tumnours. In patients with chronic granulocytic leukaemia (C.G.L.) or myeloma, for example, the disease frequently terminates in a more aggressive form. In C.G.L. this involves a transition to an acute blast cell crisis with a rapid proliferation of myeloblasts similar to A.M.L. Drugs. such as busulphan, which are effective in controlling cell proliferation in C.G.L., are ineffective at this tiome, and phase-dependent agents, such as vincristine, produce better results.
In view of the changes which occur in proliferation rates as the tumour mass enlarges, it should not be assumed that the response of a tumour in its earliest stages will be similar to that when large amounts of tumour are present late in the disease. In practice, the tumour usually proves to be difficult to treat in the latter situation, and both considerations suggest that if chemotherapy is the treatment of choice it should be used early before the tumour mass is
excessive.
An additional possible mechanism for the development of resistance is that receptors for a chemotherapeutic agent ( pressed wish by the patient for the examination. Though initially designed to be a gynaecological survey the examination at the clinic was later extended to include a general medical assessment.
Results

CYTOLOGY
The smear results are given in table II. All patients with positive smears were admitted to hospital for cone biopsy and diagnostic curettage in the first instance. Eighteen patients with abnormal smears but without malignant cells had cervical biopsies and repeat smears. None was subsequently found to have carcinoma. Four patients with positive smears had carcinoma in situ; the youngest was 30 and the oldest 66 years, and all were married with children. They were treated by extended hysterectomy. Three patients with positive smears had invasive carcinoma. They were all clinically stage 1, and aged between 42 and 49. 
